SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
jdv12296-sup-0001-TableSA-SI.docxWord document44K

Table SA. Within-person change in physiologic measures, based on measurements made within 6 months of starting TNF inhibitor, methotrexate, or phototherapy*.

Table SB. Difference-in-difference: difference between the mean change in starters of TNF inhibitor and the mean change in starters of methotrexate within the time windows shown.*

Table SC. Changes in all physiologic and metabolic outcomes 3 months following start of TNF inhibitor and methotrexate therapy.

Table SD. Changes in all physiologic and metabolic outcomes 12 months following start of TNF inhibitor and methotrexate therapy.

Table SE. Men only: Changes in physiologic and metabolic outcomes 6 months following start of TNF inhibitor and methotrexate therapy.

Table SF. Hypertensive only: Changes in physiologic and metabolic outcomes 6 months following start of TNF inhibitor and methotrexate therapy.

Table SG. Diabetes only: Changes in physiologic and metabolic outcomes 6 months following start of TNF inhibitor and methotrexate therapy.

Table SH. Obese only: Changes in physiologic and metabolic outcomes 6 months following start of TNF inhibitor and methotrexate therapy.

Table SI. Excluding patients with diabetes, hypertension, or obesity: Changes in physiologic and metabolic outcomes 6 months following start of TNF inhibitor and methotrexate therapy.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.